Where We Stand: AMCP encourages the use of generic drugs as safe, cost- effective alternatives to the equivalent brand-name products

Where We Stand: AMCP supports off‐label use of FDA‐approved drugs when medically appropriate and necessary, but opposes government‐mandated coverage of specific pharmaceuticals, whether for FDA‐approved or off‐label uses. 

Where We Stand: Appropriate access to and use of prescription medications promotes both patient well‐being and the efficient use of medical resources.

Where We Stand: AMCP opposes statutory and regulatory proposals that unduly restrict the ability of pharmacists working within managed care organizations from utilizing tools and services that are essential for the management of a prescription drug benefitFind out about Regulation of the Prescription Drug Benefit.

Where We Stand: AMCP supports the use of evidence‐based formularies that enhance the quality of pharmaceutical care while lowering medication costs

AMCP webinar that reviewed the current pre-approval support features within FormuarlyDecisions.com and insights from the active FormularyDecisions.com Payer community.

Where We Stand: AMCP supports the use of therapeutic interchange programs as a part of a comprehensive approach to quality, cost‐effective patient care.